Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 23-May-24 5:14 PM View:  | BioMarin Pharmaceutical Inc. (BMRN) | 21-May-24 | Grant | 4,720 | -- | -- | 217% 2.18K to 6.9K | |
| 28-Dec-23 1:03 PM View: | BioMarin Pharmaceutical Inc. (BMRN) | 27-Dec-23 | Grant | 2,180 | -- | -- | 100% 0 to 2.18K | |
| 17-Aug-22 4:23 PM View: | Turning Point Therapeutics,... (TPTX) | 17-Aug-22 | Disposition | 110,959 | $76.00 | $8,432,880.00 | (100%) 110.96K to 0 | |
| 11-Feb-22 6:07 PM View: | Turning Point Therapeutics,... (TPTX) | 09-Feb-22 | Grant | 62,400 | -- | -- | 123% 50.9K to 113.3K | |
| 11-Feb-22 6:07 PM View: | Turning Point Therapeutics,... (TPTX) | 09-Feb-22 | Sale | 2,971 | $36.30 | $107,847.00 | (3%) 113.3K to 110.33K | |
| 11-Feb-21 8:28 PM View: | Turning Point Therapeutics,... (TPTX) | 11-Feb-21 | Option Exercise | 8,942 | $3.20 | $28,614.40 | 18% 50.2K to 59.14K | |
| 11-Feb-21 8:28 PM View: | Turning Point Therapeutics,... (TPTX) | 11-Feb-21 | Market Option Sale (Planned) | 8,942 | $137.38 | $1,228,450.00 | (15%) 59.14K to 50.2K | 2% |
| 11-Feb-21 8:28 PM View: | Turning Point Therapeutics,... (TPTX) | 10-Feb-21 | Option Exercise | 25,392 | $3.20 | $81,254.40 | 51% 50.2K to 75.59K | |
| 11-Feb-21 8:28 PM View: | Turning Point Therapeutics,... (TPTX) | 10-Feb-21 | Market Option Sale (Planned) | 25,392 | $136.31 | $3,461,120.00 | (34%) 75.59K to 50.2K | 1% |
| 11-Feb-21 8:28 PM View: | Turning Point Therapeutics,... (TPTX) | 09-Feb-21 | Option Exercise | 25,666 | $3.20 | $82,131.20 | 51% 50.2K to 75.86K | |
| 11-Feb-21 8:28 PM View: | Turning Point Therapeutics,... (TPTX) | 09-Feb-21 | Market Option Sale (Planned) | 25,666 | $138.68 | $3,559,480.00 | (34%) 75.86K to 50.2K | 3% |
| 10-Feb-21 5:52 PM View: | Turning Point Therapeutics,... (TPTX) | 08-Feb-21 | Grant | 22,617 | -- | -- | 82% 27.58K to 50.2K | |
| 26-May-20 5:55 PM View: | Turning Point Therapeutics,... (TPTX) | 21-May-20 | Market Purchase | 4,166 | $60.00 | $249,960.00 | 18% 22.71K to 26.87K | 124% |
| 25-Mar-20 8:26 PM View: | Passage Bio, Inc. (PASG) | 24-Mar-20 | Purchase | 10,000 | $14.98 | $149,750.00 | 112% 8.9K to 18.9K | |
| 03-Mar-20 6:37 PM View: | Passage Bio, Inc. (PASG) | 03-Mar-20 | Purchase | 8,900 | $18.00 | $160,200.00 | 100% 0 to 8.9K | |
| 08-Jan-20 4:24 PM View: | Turning Point Therapeutics,... (TPTX) | 10-Dec-19 | Grant | 706 | $31.13 | $21,975.70 | 3% 22.0K to 22.71K | |
| 11-Sep-19 4:15 PM View: | Turning Point Therapeutics,... (TPTX) | 10-Sep-19 | Market Purchase | 10,000 | $45.00 | $450,000.00 | 83% 12.0K to 22.0K | 199% |
| 24-Apr-19 5:55 PM View: | Turning Point Therapeutics,... (TPTX) | 22-Apr-19 | Purchase | 12,000 | $18.00 | $216,000.00 | 100% 0 to 12.0K | |
| 21-Jun-17 6:11 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 19-Jun-17 | Grant | 150,000 | -- | -- | 100% 0 to 150.0K | |
| 06-Feb-17 7:01 PM View: | Halozyme Therapeutics, Inc. (HALO) | 03-Feb-17 | Payment of Exercise | 6,900 | $12.26 | $84,594.00 | (15%) 45.98K to 39.08K | |
| 06-Feb-17 7:01 PM View: | Halozyme Therapeutics, Inc. (HALO) | 03-Feb-17 | Option Exercise | 18,496 | -- | -- | 67% 27.48K to 45.98K | |
| 09-Jan-17 4:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 05-Jan-17 | Option Exercise | 7,500 | -- | -- | 38% 19.98K to 27.48K | |
| 05-Jul-16 4:55 PM View: | Halozyme Therapeutics, Inc. (HALO) | 30-Jun-16 | Payment of Exercise | 107 | $8.63 | $923.41 | (< 1%) 20.09K to 19.98K | |
| 05-Jul-16 4:55 PM View: | Halozyme Therapeutics, Inc. (HALO) | 30-Jun-16 | Option Exercise | 6,450 | -- | -- | 47% 13.64K to 20.09K | |
| 07-Jan-16 5:25 PM View: | Halozyme Therapeutics, Inc. (HALO) | 05-Jan-16 | Payment of Exercise | 3,257 | $16.39 | $53,382.20 | (19%) 16.89K to 13.64K | |
| 07-Jan-16 5:25 PM View: | Halozyme Therapeutics, Inc. (HALO) | 05-Jan-16 | Option Exercise | 7,500 | -- | -- | 80% 9.39K to 16.89K | |
| 04-Jan-16 8:10 PM View: | Halozyme Therapeutics, Inc. (HALO) | 31-Dec-15 | Grant | 15,050 | -- | -- | 100% 0 to 15.05K | |
| 04-Jan-16 8:10 PM View: | Halozyme Therapeutics, Inc. (HALO) | 31-Dec-15 | Payment of Exercise | 5,655 | $17.33 | $98,001.10 | (38%) 15.05K to 9.39K |